Context:
Risk markers including coronary artery calcium, carotid intima-media thickness, ankle-brachial index, brachial flow-mediated dilation, high-sensitivity C-reactive protein (CRP), and family history of coronary heart disease (CHD) have been reported to improve on the Framingham Risk Score (FRS) for prediction of CHD, but there are no direct comparisons of these markers for risk prediction in a single cohort.
Objective:
We compared improvement in prediction of incident CHD/cardiovascular disease (CVD) of these 6 risk markers within intermediate-risk participants (FRS >5%-<20%) in the Multi-Ethnic Study of Atherosclerosis (MESA).
Design, Setting, And Participants:
Of 6814 MESA participants from 6 US field centers, 1330 were intermediate risk, without diabetes mellitus, and had complete data on all 6 markers. Recruitment spanned July 2000 to September 2002, with follow-up through May 2011. Probability-weighted Cox proportional hazard models were used to estimate hazard ratios (HRs). Area under the receiver operator characteristic curve (AUC) and net reclassification improvement were used to compare incremental contributions of each marker when added to the FRS, plus race/ethnicity.
Main Outcome Measures:
Incident CHD defined as myocardial infarction, angina followed by revascularization, resuscitated cardiac arrest, or CHD death. Incident CVD additionally included stroke or CVD death.
Results:
After 7.6-year median follow-up (IQR, 7.3-7.8), 94 CHD and 123 CVD events occurred. Coronary artery calcium, ankle-brachial index, high-sensitivity CRP, and family history were independently associated with incident CHD in multivariable analyses (HR, 2.60 [95% CI, 1.94-3.50]; HR, 0.79 [95% CI, 0.66-0.95]; HR, 1.28 [95% CI, 1.00-1.64]; and HR, 2.18 [95% CI, 1.38-3.42], respectively). Carotid intima-media thickness and brachial flow-mediated dilation were not associated with incident CHD in multivariable analyses (HR, 1.17 [95% CI, 0.95-1.45] and HR, 0.95 [95% CI, 0.78-1.14]). Although addition of the markers individually to the FRS plus race/ethnicity improved AUC, coronary artery calcium afforded the highest increment (0.623 vs 0.784), while brachial flow-mediated dilation had the least (0.623 vs 0.639). For incident CHD, the net reclassification improvement with coronary artery calcium was 0.659, brachial flow-mediated dilation was 0.024, ankle-brachial index was 0.036, carotid intima-media thickness was 0.102, family history was 0.160 and high-sensitivity CRP was 0.079. Similar results were obtained for incident CVD.
Conclusions:
Coronary artery calcium, ankle-brachial index, high-sensitivity CRP, and family history were independent predictors of incident CHD/CVD in intermediate-risk individuals. Coronary artery calcium provided superior discrimination and risk reclassification compared with other risk markers.
Citing Articles
Association Between Lipoprotein (a) Levels and Coronary Artery Disease (CAD) Among Patients With or Without CAD Family History.
Tada H, Kojima N, Yamagami K, Takeji Y, Sakata K, Usui S
J Lipid Atheroscler. 2025; 14(1):120-127.
PMID: 39911955
PMC: 11791416.
DOI: 10.12997/jla.2025.14.1.120.
Computed Tomography Angiography in the Catheterization Laboratory: A Guide Towards Optimizing Coronary Interventions.
Beneki E, Dimitriadis K, Pyrpyris N, Antonopoulos A, Aznaouridis K, Antiochos P
J Cardiovasc Dev Dis. 2025; 12(1).
PMID: 39852306
PMC: 11766008.
DOI: 10.3390/jcdd12010028.
Updates on CAD risk assessment: using the coronary artery calcium score in combination with traditional risk factors.
Rezaie-Kalamtari K, Norouzi Z, Salmanipour A, Mehrali H
Egypt Heart J. 2025; 77(1):14.
PMID: 39847250
PMC: 11757844.
DOI: 10.1186/s43044-025-00608-4.
A Synergistic Effect of Remnant Cholesterol and C-Reactive Protein on Predicting the Severity of Coronary Artery Disease.
Zhang Z, Chen Q, Chen Q, Hou J, Li X, Fu J
J Inflamm Res. 2024; 17:11291-11303.
PMID: 39720698
PMC: 11668247.
DOI: 10.2147/JIR.S477860.
Coronary artery calcification score as the determinant of coronary artery disease in chronic kidney disease patients: A preliminary study.
Moradi M, Talebi A, Shavakhi S, Tarrahi M, Meraji Far F
ARYA Atheroscler. 2024; 20(3):12-20.
PMID: 39697848
PMC: 11651311.
DOI: 10.48305/arya.2023.39234.2832.
Precision Medicine for Cardiovascular Prevention and Population Health: A Bridge Too Far?.
Giugni F, Berry J, Khera A, Shah A, de Lemos J
Circulation. 2024; 150(21):1720-1731.
PMID: 39556656
PMC: 11575940.
DOI: 10.1161/CIRCULATIONAHA.124.070081.
The Relationship of Carotid and Brachial Artery Wall Thickness Measurement with Cardiovascular Risk Scoring in Individuals Living with HIV.
Bilgic Z, Kayaaslan B, Koksal M, Kaya-Kalem A, Eser F, Hasanoglu I
Infect Dis Clin Microbiol. 2024; 6(3):164-173.
PMID: 39399750
PMC: 11465432.
DOI: 10.36519/idcm.2024.323.
Coronary artery calcification score and 19 biomarkers on cardiovascular events; a 10-year follow-up DanRisk substudy.
Schaeffer M, Rasmussen J, Fredgart M, Hasific S, Jakobsen F, Steffensen F
Atheroscler Plus. 2024; 58:9-15.
PMID: 39398430
PMC: 11470180.
DOI: 10.1016/j.athplu.2024.09.003.
Association of circulating monocyte number and monocyte-lymphocyte ratio with cardiovascular disease in patients with bipolar disorder.
Chen P, Chang C, Lin Y, Chiang S, Trang N
BMC Psychiatry. 2024; 24(1):679.
PMID: 39394117
PMC: 11468788.
DOI: 10.1186/s12888-024-06105-3.
Prediction model for recommending coronary artery calcium score screening (CAC-prob) in cardiology outpatient units: A development study.
Wongyikul P, Tantraworasin A, Suwannasom P, Srisuwan T, Wannasopha Y, Phinyo P
PLoS One. 2024; 19(9):e0308890.
PMID: 39348344
PMC: 11441643.
DOI: 10.1371/journal.pone.0308890.
Computed Tomography Evaluation of Coronary Atherosclerosis: The Road Travelled, and What Lies Ahead.
Ayoub C, Scalia I, Anavekar N, Arsanjani R, Jokerst C, Chow B
Diagnostics (Basel). 2024; 14(18).
PMID: 39335775
PMC: 11431535.
DOI: 10.3390/diagnostics14182096.
2024 Guidelines of the Taiwan Society of Cardiology on the Primary Prevention of Atherosclerotic Cardiovascular Disease --- Part I.
Chao T, Lin T, Cheng C, Wu Y, Ueng K, Wu Y
Acta Cardiol Sin. 2024; 40(5):479-543.
PMID: 39308649
PMC: 11413940.
DOI: 10.6515/ACS.202409_40(5).20240724A.
The relationship of cardiorespiratory fitness, physical activity, and coronary artery calcification to cardiovascular disease events in CARDIA participants.
Gerber Y, Pettee Gabriel K, Jacobs Jr D, Liu J, Rana J, Sternfeld B
Eur J Prev Cardiol. 2024; 32(1):52-62.
PMID: 39158112
PMC: 11700624.
DOI: 10.1093/eurjpc/zwae272.
Epicardial fat modifies the relationship between coronary calcium score and all-cause mortality: The St. Francis Heart Study.
Chen L, Scheiner J, Nashta N, Weber J, Zhou Q, Rapelje K
Am J Prev Cardiol. 2024; 19:100689.
PMID: 39005754
PMC: 11245900.
DOI: 10.1016/j.ajpc.2024.100689.
New look at the power of zero coronary artery calcium (CAC) in Asian population: a systemic review and meta-analysis.
Chen C, Wu Y, Yang S, Wu F
Cardiovasc Diagn Ther. 2024; 14(3):377-387.
PMID: 38975010
PMC: 11223936.
DOI: 10.21037/cdt-23-474.
Assessing mortality risk in Type 2 Diabetes patients with prolonged ASCVD risk factors: the inclusive Poh-Ai predictive scoring system with CAC Score integration.
Lei M, Hsu Y, Chung S, Chen C, Chen W, Chen W
Diabetol Metab Syndr. 2024; 16(1):104.
PMID: 38764060
PMC: 11103845.
DOI: 10.1186/s13098-024-01341-9.
Optimizing the Clinical Direction of Artificial Intelligence With Health Policy: A Narrative Review of the Literature.
Lakkimsetti M, Devella S, Patel K, Dhandibhotla S, Kaur J, Mathew M
Cureus. 2024; 16(4):e58400.
PMID: 38756258
PMC: 11098056.
DOI: 10.7759/cureus.58400.
C-Reactive Protein and Long-Term Prognosis in Adult Patients with Congenital Heart Disease.
Martinez-Quintana E, Alcantara-Castellano M, Garcia-Suarez M, Rodriguez-Gonzalez F
J Clin Med. 2024; 13(8).
PMID: 38673472
PMC: 11050825.
DOI: 10.3390/jcm13082199.
Clinical impact of cardiovascular calcifications on stroke incidence in primary prevention: analysis in NADESICO study.
Wada S, Iwanaga Y, Nakai M, Miyamoto Y, Noguchi T
Heart Vessels. 2024; 39(8):754-762.
PMID: 38568474
DOI: 10.1007/s00380-024-02394-6.
Major Limitations of Cardiovascular Risk Scores.
Talha I, Elkhoudri N, Hilali A
Cardiovasc Ther. 2024; 2024:4133365.
PMID: 38449908
PMC: 10917477.
DOI: 10.1155/2024/4133365.